Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FBGG0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,367
Award facts
- Contract value 100% obligated
- $44,367.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,367.15 to Amerisourcebergen Drug Corp for 90-count tablets of Gemtesa 75 mg, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026.
Gemtesa (mirabegron) is a beta-3 agonist medication primarily used to treat overactive bladder, a common condition requiring ongoing pharmaceutical support within military treatment facilities and veterans' healthcare programs. As the parent company of Amerisourcebergen Drug Corp, Cencora, Inc. holds the primary IDC with the Defense Logistics Agency through December 31, 2031, enabling comprehensive delivery of pharmaceutical products and medical supplies to support global military healthcare operations. This delivery order exemplifies the routine pharmaceutical procurement activities executed under these framework agreements to ensure consistent supply of essential medications to federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FBGG0?
SPE2DR26FBGG0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FBGG0 worth?
The government has obligated $44,367 on SPE2DR26FBGG0.
Is contract SPE2DR26FBGG0 an order under another contract?
Yes. SPE2DR26FBGG0 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGG0 competed?
The extent of competition for SPE2DR26FBGG0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award